Correlation Between Merrimack Pharmaceuticals and Instil Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merrimack Pharmaceuticals and Instil Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merrimack Pharmaceuticals and Instil Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merrimack Pharmaceuticals and Instil Bio, you can compare the effects of market volatilities on Merrimack Pharmaceuticals and Instil Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merrimack Pharmaceuticals with a short position of Instil Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merrimack Pharmaceuticals and Instil Bio.

Diversification Opportunities for Merrimack Pharmaceuticals and Instil Bio

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Merrimack and Instil is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Merrimack Pharmaceuticals and Instil Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instil Bio and Merrimack Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merrimack Pharmaceuticals are associated (or correlated) with Instil Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instil Bio has no effect on the direction of Merrimack Pharmaceuticals i.e., Merrimack Pharmaceuticals and Instil Bio go up and down completely randomly.

Pair Corralation between Merrimack Pharmaceuticals and Instil Bio

Given the investment horizon of 90 days Merrimack Pharmaceuticals is expected to generate 43.35 times less return on investment than Instil Bio. But when comparing it to its historical volatility, Merrimack Pharmaceuticals is 6.3 times less risky than Instil Bio. It trades about 0.01 of its potential returns per unit of risk. Instil Bio is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,780  in Instil Bio on October 25, 2024 and sell it today you would earn a total of  640.00  from holding Instil Bio or generate 35.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy23.89%
ValuesDaily Returns

Merrimack Pharmaceuticals  vs.  Instil Bio

 Performance 
       Timeline  
Merrimack Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merrimack Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Merrimack Pharmaceuticals is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Instil Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Instil Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Merrimack Pharmaceuticals and Instil Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merrimack Pharmaceuticals and Instil Bio

The main advantage of trading using opposite Merrimack Pharmaceuticals and Instil Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merrimack Pharmaceuticals position performs unexpectedly, Instil Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instil Bio will offset losses from the drop in Instil Bio's long position.
The idea behind Merrimack Pharmaceuticals and Instil Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine